PEP
33
-3
OI
30
5
XYL
33
2
NRG
37
-2
WMT
70
2
ORLY
48
-4
QCOM
57
-2
FAST
42
-2
CVS
32
3
ADT
32
4
TGNA
53
3
FMC
20
-2
ECL
54
-3
MAT
45
2
HON
64
4
TXT
48
2
XRX
57
-2
DG
14
2
ESS
51
3
GM
63
2
PEP
33
-3
OI
30
5
XYL
33
2
NRG
37
-2
WMT
70
2
ORLY
48
-4
QCOM
57
-2
FAST
42
-2
CVS
32
3
ADT
32
4
TGNA
53
3
FMC
20
-2
ECL
54
-3
MAT
45
2
HON
64
4
TXT
48
2
XRX
57
-2
DG
14
2
ESS
51
3
GM
63
2
Financhill
Back

electroCore 10K Form

Buy
77

ECOR
electroCore

Last Price:
$16.70
Seasonality Move:
1.04%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ECOR News And Ratings

See the #1 stock for the next 7 days that we like better than ECOR

ECOR Financial Statistics

Sales & Book Value

Annual Sales: $16M
Cash Flow: $-1.4M
Price / Cash Flow: 0
Annual Sales: $1.45
Price / Book: 11.62

Profitability

EPS (TTM): -1.77000
Net Income (TTM): $-12.7M
Gross Margin: $13.2M
Return on Equity: -144.52%
Return on Assets: -67.86%

electroCore Earnings Forecast

Key electroCore Financial Ratios

  • The Gross Profit Margin over the past 8 years for ECOR is 82.51%.
  • The Selling, General & Administrative Expenses for ECOR have been equal to 169.52% of Gross Profit Margin.
  • The Research & Development expenses have been 33.19% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of ECOR is -117.49% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 4 years.

electroCore Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: ECOR
CUSIP: 28531P
Website: electrocore.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 2.12
Quick Ratio: 1.71

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

ECOR Technical Analysis vs Fundamental Analysis

Buy
77
electroCore (ECOR) is a Buy

Is electroCore a Buy or a Sell?

  • electroCore stock is rated a Buy
    The current electroCore [ECOR] share price is $16.76. The Score for ECOR is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.